Growth Metrics

Ceribell (CBLL) Asset Utilization Ratio (2024 - 2026)

Ceribell posted quarterly Asset Utilization Ratio of 0.51 for Q1 2026, up 56.0% year-on-year from 0.33 in Q1 2025, and up 12.86% on a QoQ basis from 0.45 in Q4 2025.

Ceribell (CBLL) has 3 years of Asset Utilization Ratio data on file, last reported at 0.51 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 56.0% year-over-year to 0.51; the trailing twelve-month figure through Mar 2026 stood at 0.51 (up 56.0% YoY), and the FY2025 full-year result was 0.42, down 8.13% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.51, up from 0.45 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.51 in Q1 2026 and bottomed at 0.33 in Q1 2025.
  • The 3-year median for Asset Utilization Ratio is 0.43 (2025), against an average of 0.42.
  • The widest annual swing landed in 2025, when Asset Utilization Ratio retreated 6.2%; it then jumped 56.0% in 2026.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.48 in 2024, then dropped by 6.2% to 0.45 in 2025, then climbed by 12.86% to 0.51 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.51 (Q1 2026), 0.45 (Q4 2025), and 0.41 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Ceribell 666.26 Mn 525.07 Mn 23.12 Mn 0.51

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.51
Dec 31, 2025 0.45
Sep 30, 2025 0.41
Jun 30, 2025 0.37
Mar 31, 2025 0.33
Dec 31, 2024 0.48